One particular situation where ECN U.S.’s support will forever be remembered and much valued is when both Hospital 57357 and the National cancer Institute suffered a severe shortage of one vital chemotherapy drug: the 6-MP back in 2013. Thanks to the efforts of Egyptian American pharmacist Dr. Mohammed El-Adma who emigrated to the U.S. in 1988, important supplies of the medication to cover a 6 month period were rapidly facilitated and shipped to Egypt through the help of the Egyptian Embassy in the U.S. It is noteworthy that 6-MP is the main drug in the treatment of ALL, a common leukemia disease in children with cancer.
But the main direct contributions to Patient care remain to be the donations allocated by ECN members to the naming opportunity program that Egypt Cancer Network 57357 shares with its partners (AFNCI) and the Children’s Cancer Hospital Egypt 57357 (CCHE). The Naming Opportunity program is specially crafted to commemorate your loved ones while simultaneously providing the framework from which CCHE and the National Cancer Institute (NCI) can continue to treat Egypt’s cancer-stricken children. Indeed donations to this program directly serve to increase the endowment funds that ensure a steady and constant income which is utilized in offering top quality healthcare services to our patients at Hospital 57357 and the National Cancer Institute’s new outpatient clinics.
